StockSelector.com
  Research, Select, & Monitor Friday, April 03, 2020 7:27:40 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Tandem Diabetes Care, Inc.$64.27$4.227.03%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Tandem Diabetes Care, Inc. has an overall rank of 1147 out of 7217 stocks based on 13 positive rankings and 9 negative rankings.

Positive Rankings
Beat Whisper
According to EarningsWhispers.com, Tandem Diabetes Care beat the Earnings Whisper number when it last reported earnings. Statistics show that companies that have beat the Earnings Whisper number outperform the market in the short-term.
Positive Guidance
Within the past 90 days Tandem Diabetes Care has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
SSValue
The StockSelector Value for Tandem Diabetes Care is $1,999.72. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Tandem Diabetes Care is ranked 111.
Up EPS Surprise
Tandem Diabetes Care beat the consensus earnings estimate when it last reported quarterly earnings.
Historic Revenue Growth
Tandem Diabetes Care rank is 139
PEGValue
Tandem Diabetes Care has a PEG Value of $199.03. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 209.68% in the next year. Among companies with a PEG Value above the current stock price, Tandem Diabetes Care is ranked 278.
Estimated Revenue Growth
Tandem Diabetes Care rank is 312
10 Day Gain
Tandem Diabetes Care rank is 493
Low vPut/Call
Tandem Diabetes Care has a low Put/Call ratio of 0.41 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Tandem Diabetes Care is ranked 760.
Debt-to-Equity
Tandem Diabetes Care rank is 1189
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Tandem Diabetes Care is ranked 1222.
Low Put/Call
Tandem Diabetes Care has a low Put/Call ratio of 0.48 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Tandem Diabetes Care is ranked 1267.
Target Prices
The average analysts' target price is $82.00 for Tandem Diabetes Care using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Tandem Diabetes Care is ranked 1376.
Negative Rankings
Price-to-Book
Tandem Diabetes Care rank is 114
Negative Cash Growth
Tandem Diabetes Care rank is 123
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Tandem Diabetes Care is ranked 158.
Price-to-Sales
Tandem Diabetes Care rank is 337
Down Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have decreased by a combined (18.42%). Among companies that have had their estimates lowerec within the past month, Tandem Diabetes Care is ranked 375.
Negative ROE
Tandem Diabetes Care rank is 987
Negative ROA
Tandem Diabetes Care rank is 1032
Negative Net Margin
Tandem Diabetes Care rank is 1062
90 Day Loss
Tandem Diabetes Care rank is 4377







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.